167 related articles for article (PubMed ID: 28553648)
1. Serum Vaspin Concentration in Elderly Type 2 Diabetes Mellitus Patients with Differing Body Mass Index: A Cross-Sectional Study.
Yang W; Li Y; Tian T; Wang L
Biomed Res Int; 2017; 2017():4875026. PubMed ID: 28553648
[No Abstract] [Full Text] [Related]
2. Serum vaspin concentration in elderly patients with type 2 diabetes mellitus and macrovascular complications.
Yang W; Li Y; Tian T; Wang L; Lee P; Hua Q
BMC Endocr Disord; 2017 Oct; 17(1):67. PubMed ID: 29065866
[TBL] [Abstract][Full Text] [Related]
3. Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes.
Yang L; Chen SJ; Yuan GY; Wang D; Chen JJ
Genet Mol Res; 2015 Sep; 14(3):11356-61. PubMed ID: 26436376
[TBL] [Abstract][Full Text] [Related]
4. Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study.
Jian W; Peng W; Xiao S; Li H; Jin J; Qin L; Dong Y; Su Q
PLoS One; 2014; 9(4):e94763. PubMed ID: 24732788
[TBL] [Abstract][Full Text] [Related]
5. Serum vaspin concentrations in human obesity and type 2 diabetes.
Youn BS; Klöting N; Kratzsch J; Lee N; Park JW; Song ES; Ruschke K; Oberbach A; Fasshauer M; Stumvoll M; Blüher M
Diabetes; 2008 Feb; 57(2):372-7. PubMed ID: 17991760
[TBL] [Abstract][Full Text] [Related]
6. Short-term continuous subcutaneous insulin infusion decreases the plasma vaspin levels in patients with type 2 diabetes mellitus concomitant with improvement in insulin sensitivity.
Li K; Li L; Yang M; Liu H; Liu D; Yang H; Boden G; Yang G
Eur J Endocrinol; 2011 Jun; 164(6):905-10. PubMed ID: 21471167
[TBL] [Abstract][Full Text] [Related]
7. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
[TBL] [Abstract][Full Text] [Related]
8. Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance.
Chang HM; Lee HJ; Park HS; Kang JH; Kim KS; Song YS; Jang YJ
Obesity (Silver Spring); 2010 Nov; 18(11):2105-10. PubMed ID: 20339362
[TBL] [Abstract][Full Text] [Related]
9. Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals.
Moradi S; Mirzaei K; Abdurahman AA; Keshavarz SA; Hossein-Nezhad A
Eur J Nutr; 2016 Apr; 55(3):1297-305. PubMed ID: 26058881
[TBL] [Abstract][Full Text] [Related]
10. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study.
Yang W; Li Y; Wang JY; Han R; Wang L
Cardiovasc Diabetol; 2018 May; 17(1):75. PubMed ID: 29848323
[TBL] [Abstract][Full Text] [Related]
12. Association between vaspin level and coronary artery disease in patients with type 2 diabetes.
Hao F; Zhang H; Zhu J; Kuang H; Yu Q; Bai M; Mu J
Diabetes Res Clin Pract; 2016 Mar; 113():26-32. PubMed ID: 26972957
[TBL] [Abstract][Full Text] [Related]
13. Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans.
von Loeffelholz C; Möhlig M; Arafat AM; Isken F; Spranger J; Mai K; Randeva HS; Pfeiffer AF; Weickert MO
Eur J Endocrinol; 2010 Mar; 162(3):507-13. PubMed ID: 19952124
[TBL] [Abstract][Full Text] [Related]
14. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
[TBL] [Abstract][Full Text] [Related]
15. Vaspin serum concentration in patients with type 2 diabetes and carotid plaque.
Li Z; Ma C; Li L; Pan X; Chen L
J Int Med Res; 2012; 40(5):1670-6. PubMed ID: 23206449
[TBL] [Abstract][Full Text] [Related]
16. Concentrations of omentin and vaspin versus insulin resistance in obese individuals.
Sperling M; Grzelak T; Pelczyńska M; Jasinska P; Bogdanski P; Pupek-Musialik D; Czyzewska K
Biomed Pharmacother; 2016 Oct; 83():542-547. PubMed ID: 27449535
[TBL] [Abstract][Full Text] [Related]
17. Obese type 2 diabetes mellitus patients have higher serum vaspin concentrations.
Dai R; Dong Z; Qian Y; Han Y
J Diabetes; 2016 May; 8(3):445-7. PubMed ID: 26676943
[No Abstract] [Full Text] [Related]
18. Vaspin and its correlation with insulin sensitivity indices in obese children.
Suleymanoglu S; Tascilar E; Pirgon O; Tapan S; Meral C; Abaci A
Diabetes Res Clin Pract; 2009 Jun; 84(3):325-8. PubMed ID: 19356820
[TBL] [Abstract][Full Text] [Related]
19. Serum vaspin concentrations in girls with anorexia nervosa.
Oświęcimska J; Suwała A; Świętochowska E; Ostrowska Z; Gorczyca P; Ziora-Jakutowicz K; Machura E; Szczepańska M; Hyla-Klekot L; Kukla M; Ziora D; Ziora K
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):681-6. PubMed ID: 27054597
[TBL] [Abstract][Full Text] [Related]
20. Reduced serum vaspin concentrations in obese children following short-term intensive lifestyle modification.
Lee MK; Jekal Y; Im JA; Kim E; Lee SH; Park JH; Chu SH; Chung KM; Lee HC; Oh EG; Kim SH; Jeon JY
Clin Chim Acta; 2010 Mar; 411(5-6):381-5. PubMed ID: 20018186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
